Acquisition strengthens EY’s Veeva Centers of Excellence, expanding clinical, regulatory, and commercial services for global pharma and biotech companies
Datamatics will automate the Medication Administration Record process by integrating its intelligent automation products, TruBot and TruCap+
Phase 3 program for NDV-01 in non-muscle invasive bladder cancer expected to begin in the first half of 2026
Roche will unveil the primary results from the phase III evERA Breast Cancer study evaluating giredestrant
UZEDY (risperidone) extended-release injectable suspension for subcutaneous use is indicated for use every one or two months for the treatment of schizophrenia in adults
SkinMedica redefines luxury skincare with reimagined packaging and new HA5 hydra collagen water burst moisturizer
Lupin's partnership program is designed to foster collaborations with companies looking to extend their product lifecycles
Stephan brings more than 20 years of leadership experience in the pharmaceutical industry
IMCD engaged with manufacturers, formulators, and brand leaders, offering valuable insights into evolving consumer trends
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
Subscribe To Our Newsletter & Stay Updated
